Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumour Response,”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01963702
What this trial is testing

A Phase II Trial of Exploring the Predictive Factors of TX and XELOX Regimen in the First Line Treatment of MGC

Who this might be right for
Gastric Cancer
Fudan University 120
Not applicableLooking for participantsNCT07064330
What this trial is testing

Next-gen Flow Cytometry to Find Immune Profiles, Treatment Response, and Toxicity Markers in Skin Cancer Patients Treated With Cemiplimab.

Who this might be right for
Cutaneous Squamous Cell Carcinoma (CSCC)
Instituto de Investigación Biomédica de Salamanca 30
Testing effectiveness (Phase 2)WithdrawnNCT04230031
What this trial is testing

Phase II Study of Daratumumab Pre-Mobilization and Post-ASCT in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Ended earlyNCT00602329
What this trial is testing

MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Abramson Cancer Center at Penn Medicine 5
Not applicableStudy completedNCT00953537
What this trial is testing

Predicting Response to Capecitabine in Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Centre Antoine Lacassagne 303
Not applicableNot Yet RecruitingNCT07179445
What this trial is testing

Analysis of Deoxyribonucleic Acid and Ribonucleic Acid Next-Generation Sequencing in Non-Small Cell Lung Cancer Patients Without Pathological Complete Response Following Neoadjuvant Immunotherapy

Who this might be right for
NSCLC
Tianjin Medical University Cancer Institute and Hospital 300
Not applicableStudy completedNCT01650077
What this trial is testing

Therapeutic Response of Patients With Soft Tissue Sarcoma According to CHOI Criteria

Who this might be right for
Soft Tissue Sarcoma
Centre Oscar Lambret 134
Not applicableUnknownNCT04273477
What this trial is testing

Radiomics-based Artificial Intelligence System to Predict Neoadjuvant Treatment Response in Rectal Cancer

Who this might be right for
Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 100
Testing effectiveness (Phase 2)UnknownNCT04635956
What this trial is testing

Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas

Who this might be right for
ChemotherapyAnti-pd-1 AntibodyCervical Neuroendocrine Carcinoma+4 more
Lei Li 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05574101
What this trial is testing

Radiation Therapy and Cemiplimab for People With Skin Cancer

Who this might be right for
Cutaneous Squamous Cell CarcinomaSkin CancerSquamous Cell Carcinoma+4 more
Memorial Sloan Kettering Cancer Center 34
Not applicableStudy completedNCT06648512
What this trial is testing

Association of Ex Vivo Drug Response ( EVDR) and Clinical Outcome in Acute Myeloid Leukaemia (EXCYTE-2)

Who this might be right for
Acute Myeloid Leukemia (AML)Acute Myeloid Leukemia (AML) Relapse
Exscientia AI Limited 91
Not applicableLooking for participantsNCT06396312
What this trial is testing

Deep Phenotyping for Clinical Inferring Response in Treatment Resistant Depression

Who this might be right for
Depressive; Disorder, Major, Single Episode, Major, With Psychotic SymptomsDepressive; Disorder, Major, Single Episode, Major (Without Psychotic Symptoms)Depressive Disorder, Major, Recurrent, With Psychotic Symptoms+4 more
Max-Planck-Institute of Psychiatry
Not applicableLooking for participantsNCT07354295
What this trial is testing

Integrating Multimodal AI to Predict Treatment Response and Refine Risk Stratification in Esophageal Cancer （Radiogenomics-Esophagus）

Who this might be right for
Esophageal Cancer
Shu Peng 1,500
Large-scale testing (Phase 3)Active Not RecruitingNCT02568839
What this trial is testing

Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer

Who this might be right for
Early-Stage Breast CarcinomaHER-2 Positive Breast Cancer
Thomas Hatschek 202
Not applicableLooking for participantsNCT06182657
What this trial is testing

The Prognostic Value of the Degree of Pathological Response of Induction Chemotherapy for NPC

Who this might be right for
Nasopharyngeal CarcinomaPathologic Complete ResponseTumor Microenvironment
Jiangxi Provincial Cancer Hospital 300
Very early researchActive Not RecruitingNCT05477823
What this trial is testing

Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 30
Testing effectiveness (Phase 2)UnknownNCT01047969
What this trial is testing

Avoiding Surgery in Rectal Cancer After Pre-Operative Therapy

Who this might be right for
Rectal Adenocarcinoma
Royal Marsden NHS Foundation Trust 99
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07400094
What this trial is testing

Neoadjuvant Chemoimmunotherapy (Camrelizumab + Paclitaxel + Carboplatin) for Resectable HNSCC

Who this might be right for
Squamous Cell Carcinoma of Head and NeckLaryngeal NeoplasmsOral Cavity Neoplasm
National Medical Research Radiological Centre of the Ministry of Health of Russia 50
Not applicableStudy completedNCT02175095
What this trial is testing

[18F]FLT-PET as a Predictive Imaging Biomaker of Treatment Responses to Regorafenib

Who this might be right for
Colorectal Cancer
Asan Medical Center 68
Not applicableStudy completedNCT01381705
What this trial is testing

Biomarkers in Predicting Response to Rituximab Treatment in Samples From Patients With Indolent Follicular Lymphoma

Who this might be right for
Lymphoma
ECOG-ACRIN Cancer Research Group 259
Next Page
130